||
Shinya Yamanaka, born in 1962 in Osaka Prefecture, Japan, graduated from Kobe University and Osaka Municipal University with a doctor's degree. He is currently the director of the IPS Cell Research Institute of Kyoto University, a professor of the University of California, San Francisco, and a senior researcher of the Gladstone Institute. [1-3]
In 2012, Shinami Yamanaka, then a professor at Kyoto University, won the Nobel Prize in Physiology or Medicine for his research on "somatic reprogramming technology". [1-3]
山中伸弥(Shinya Yamanaka),1962年出生于日本大阪府,博士学位,毕业于神户大学和大阪市立大学。现任京都大学IPS细胞研究所所长,美国加利福尼亚大学旧金山分校教授及下属的格拉德斯通研究所高级研究员。 [1-3]
2012年,因对“体细胞重编程技术”的研究,时任京都大学教授的山中伸弥获得当年的诺贝尔生理或医学奖。 [1-3]
https://baike.baidu.com/item/%E5%B1%B1%E4%B8%AD%E4%BC%B8%E5%BC%A5/445798?fromModule=lemma_inlink
https://pubmed.ncbi.nlm.nih.gov/24255017/
Review
Angew Chem Int Ed Engl
. 2013 Dec 23;52(52):13900-9.
doi: 10.1002/anie.201306721. Epub 2013 Nov 19.
Affiliations expand
PMID: 24255017
No abstract available
Keywords: cell therapies; cloning; drug discovery; pluripotent stem cells; reprogramming.
A new era of disease modeling and drug discovery using induced pluripotent stem cells.
Arch Pharm Res. 2017 Jan;40(1):1-12. doi: 10.1007/s12272-016-0871-0. Epub 2016 Dec 5.PMID: 27921262 Review.
Induced pluripotency: history, mechanisms, and applications.
Genes Dev. 2010 Oct 15;24(20):2239-63. doi: 10.1101/gad.1963910.PMID: 20952534 Free PMC article. Review.
Stem Cells Transl Med. 2016 Jul;5(7):870-82. doi: 10.5966/sctm.2015-0250. Epub 2016 May 9.PMID: 27160704 Free PMC article.
Oncotarget. 2017 Jul 18;8(29):47344-47355. doi: 10.18632/oncotarget.17185.PMID: 28476045 Free PMC article.
Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
Epigenomics. 2016 Aug;8(8):1131-49. doi: 10.2217/epi-2016-0032. Epub 2016 Jul 15.PMID: 27419933 Free PMC article. Review.
Therapy Development by Genome Editing of Hematopoietic Stem Cells.
Cells. 2021 Jun 14;10(6):1492. doi: 10.3390/cells10061492.PMID: 34198536 Free PMC article. Review.
What Can Chemical Carcinogenesis Shed Light on the LNT Hypothesis in Radiation Carcinogenesis?
Dose Response. 2019 Sep 18;17(3):1559325819876799. doi: 10.1177/1559325819876799. eCollection 2019 Jul-Sep.PMID: 31565039 Free PMC article.
Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.
J Parkinsons Dis. 2018;8(4):479-493. doi: 10.3233/JPD-181353.PMID: 30149462 Free PMC article. Review.
Sci Rep. 2018 Jul 19;8(1):10955. doi: 10.1038/s41598-018-29339-0.PMID: 30026469 Free PMC article.
Tendency of K562 Chronic Myeloid Leukemia Cells Towards Cell Reprogramming.
Turk J Haematol. 2018 Nov 13;35(4):260-264. doi: 10.4274/tjh.2018.0106. Epub 2018 May 21.PMID: 29781803 Free PMC article.
Cell- and Tissue-Based Therapy
Cellular Reprogramming
Drug Discovery
Humans
Induced Pluripotent Stem Cells / chemistry
Induced Pluripotent Stem Cells / metabolism*
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2025-1-10 05:09
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社